Cargando…
Genetic factors affecting patient responses to pancreatic cancer treatment
Cancer of the exocrine pancreas is a malignancy with a high lethal rate. Surgical resection is the only possible curative mode of treatment. Metastatic pancreatic cancer is incurable with modest results from the current treatment options. New genomic information could prove treatment efficacy. An in...
Autores principales: | Fotopoulos, George, Syrigos, Konstantinos, Saif, Muhammad Wasif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049553/ https://www.ncbi.nlm.nih.gov/pubmed/27708512 http://dx.doi.org/10.20524/aog.2016.0056 |
Ejemplares similares
-
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
por: Kotteas, Elias A, et al.
Publicado: (2016) -
Role and Cost Effectiveness of PET/CT in Management of Patients with Cancer
por: Saif, Muhammad Wasif, et al.
Publicado: (2010) -
CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy
por: Saif, Muhammad Wasif, et al.
Publicado: (2010) -
Role of Vitamin D in the Prevention of Pancreatic Cancer
por: Bulathsinghala, Pubudu, et al.
Publicado: (2010) -
Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma
por: SAIF, MUHAMMAD WASIF, et al.
Publicado: (2014)